COO coopercos.com: Multiplikator Forward P/S

Logo grafis CooperVision (COO)

Collaboration with reproductive clinics and ophthalmologists requires constant investment, as reflected in the forward price-to-sales valuation trend, where the latest value is recorded as 1.80. Stability is provided by the demand inertia for daily disposable lenses, which serves as a profit generator. This resilience is further bolstered by streamlined international logistics and warehouse automation, ensuring high distribution profitability for The Cooper Companies (COO).

coopercos.com - Rasio kapitalisasi marang dodolan sing dikarepake COO (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan CooperSurgical (COO)

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:CooperCompanies (COO)
Sampel barang The Cooper Companies

To determine the fundamental value of The Cooper Companies (COO), an investor must compare market capitalization with projected sales volume. By analyzing the forward price-to-sales valuation chart, one can identify whether the asset is overvalued or possesses growth potential through the ratio of current price to expected revenue. The stability of this multiple is supported by the ownership of high-tech manufacturing plants in the US and Europe, which ensure the predictability of lens supplies.

Pesaing wigati

Multiplikator Forward P/S BSX (Boston Scientific Corporation)|Edwards (EW) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ResMed Corp - Multiplikator Forward P/S|PODD (Insulet Inc.) - Kapitalisasi marang prakiraan pendapatan|ZBH: Multiplikator Forward P/S|ALGN - Rasio kapitalisasi marang dodolan sing dikarepake|GMED (Globus Medical) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TransMedics Group Inc (TMDX)|Multiplikator Forward P/S ATEC|Multiplikator Forward P/S Artivion Corp (AORT)|Rasio rega marang prakiraan pendapatan Enovis Corporation ENOV|integralife.com - Rasio rega marang prakiraan pendapatan|ESTA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan BBNX (Beta Bionics, Inc.)|IRMD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Embecta Health (EMBC)|Rasio rega marang prakiraan pendapatan Tandem Diabetes Care|AXGN - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SIBN (SI-BONE)|Multiplikator Forward P/S Orthofix Medical (OFIX)|Multiplikator Forward P/S BVS (Bioventus Corp)|Rasio kapitalisasi marang dodolan sing dikarepake OrthoPediatrics Corp (KIDS)|TMCI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stereotaxis Corporation STXS|Rasio rega marang prakiraan pendapatan Neuronetics, Inc. (STIM)|sightsciences.com - Kapitalisasi marang prakiraan pendapatan|Orchestra BioMed, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ANIK (Anika Therapeutics Inc.)|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|Xtant Medical - Rega forward marang dodolan|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Modular Med MODD|Multiplikator forward rega marang pendapatan MYO (Myomo, Inc)|COCH (Envoy Medical Inc) - Rega forward marang dodolan|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|NVNO - Multiplikator forward rega marang pendapatan|SINT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Autonomix Medical (AMIX)|Rasio rega marang prakiraan pendapatan INVO Fertility Inc|bonebiologics.com - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S AXNX|BIOL - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|Rega forward marang dodolan FNA|INVO: Multiplikator forward rega marang pendapatan